Towards a goal-oriented methodology for clinical-guideline-based management recommendations for patients with multimorbidity: GoCom and its preliminary evaluation

被引:18
|
作者
Kogan, Alexandra [1 ]
Peleg, Mor [1 ]
Tu, Samson W. [2 ]
Allon, Raviv [3 ]
Khaitov, Natanel [3 ]
Hochberg, Irit [3 ,4 ]
机构
[1] Univ Haifa, Dept Informat Syst, Aba Hushi 199, IL-3498838 Haifa, Israel
[2] Stanford Univ, Ctr BioMed Informat Res, Stanford, CA 94305 USA
[3] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Haifa, Israel
[4] Rambam Med Ctr, Inst Endocrinol Diabet & Metab, Haifa, Israel
基金
以色列科学基金会;
关键词
Multimorbidity; Comorbidity; Decision-support; Computer-interpretable guidelines; DECISION-SUPPORT; MITIGATION; KNOWLEDGE; FRAMEWORK; SYSTEM; CARE;
D O I
10.1016/j.jbi.2020.103587
中图分类号
TP39 [计算机的应用];
学科分类号
081203 ; 0835 ;
摘要
Patients with chronic multimorbidity are becoming more common as life expectancy increases, making it necessary for physicians to develop complex management plans. We are looking at the patient management process as a goal-attainment problem. Hence, our aim is to develop a goal-oriented methodology for providing decision support for managing patients with multimorbidity continuously, as the patient's health state is progressing and new goals arise (e.g., treat ulcer, prevent osteoporosis). Our methodology allows us to detect and mitigate inconsistencies among guideline recommendations stemming from multiple clinical guidelines, while consulting medical ontologies and terminologies and relying on patient information standards. This methodology and its implementation as a decision-support system, called GoCom, starts with computer-interpretable clinical guidelines (CIGs) for single problems that are formalized using the PROforma CIG language. We previously published the architecture of the system as well as a CIG elicitation guide for enriching PROforma tasks with properties referring to vocabulary codes of goals and physiological effects of management plans. In this paper, we provide a formalization of the conceptual model of GoCom that generates, for each morbidity of the patient, a patient-specific goal tree that results from the PROforma engine's enactment of the CIG with the patient's data. We also present the "Controller" algorithm that drives the GoCom system. Given a new problem that a patient develops, the Controller detects inconsistencies among goals pertaining to different comorbid problems and consults the CIGs to generate alternative non-conflicted and goal-oriented management plans that address the multiple goals simultaneously. In this stage of our research, the inconsistencies that can be detected are of two types - starting vs. stopping medications that belong to the same medication class hierarchy, and detecting opposing physiological effect goals that are specified in concurrent CIGs (e.g., decreased blood pressure vs. increased blood pressure). However, the design of GoCom is modular and generic and allows the future introduction of additional interaction detection and mitigation strategies. Moreover, GoCom generates explanations of the alternative non-conflicted management plans, based on recommendations stemming from the clinical guidelines and reasoning patterns. GoCom's functionality was evaluated using three cases of multimorbidity interactions that were checked by our three clinicians. Usefulness was evaluated with two studies. The first evaluation was a pilot study with ten 6th year medical students and the second evaluation was done with 27 6th medical students and interns. The participants solved complex realistic cases of multimorbidity patients: with and without decision-support, two cases in the first evaluation and 6 cases in the second evaluation. Use of GoCom increased completeness of the patient management plans produced by the medical students from 0.44 to 0.71 (P-value of 0.0005) in the first evaluation, and from 0.31 to 0.78 (P-value < 0.0001) in the second evaluation. Correctness in the first evaluation was very high with (0.98) or without the system (0.91), with non-significant difference (P-value >= 0.17). In the second evaluation, use of GoCom increased correctness from 0.68 to 0.83 (P-value of 0.001). In addition, GoCom's explanation and visualization were perceived as useful by the vast majority of participants. While GoCom's detection of goal interactions is currently limited to detection of starting vs. stopping the same medication or medication subclasses and detecting conflicting physiological effects of concurrent medications, the evaluation demonstrated potential of the system for improving clinical decision-making for multimorbidity patients.
引用
收藏
页数:37
相关论文
共 11 条
  • [1] A Goal-Oriented Methodology for Treatment of Patients with Multimorbidity - Goal Comorbidities (GoCom) Proof-of-Concept Demonstration
    Kogan, Alexandra
    Peleg, Mor
    Tu, Samson W.
    Allon, Raviv
    Khaitov, Natanel
    Hochberg, Irit
    ARTIFICIAL INTELLIGENCE IN MEDICINE, AIME 2022, 2022, 13263 : 426 - 430
  • [2] A Method for Goal-Oriented Guideline Modeling in PROforma and Its Preliminary Evaluation
    Peleg, Mor
    Kogan, Alexandra
    Tu, Samson W.
    ARTIFICIAL INTELLIGENCE IN MEDICINE: KNOWLEDGE REPRESENTATION AND TRANSPARENT AND EXPLAINABLE SYSTEMS, AIME 2019, 2019, 11979 : 17 - 28
  • [3] Towards a Methodology for Goal-Oriented Enterprise Management
    Cardoso, Evellin Cristine Souza
    17TH IEEE INTERNATIONAL ENTERPRISE DISTRIBUTED OBJECT COMPUTING CONFERENCE WORKSHOPS (EDOCW 2013), 2013, : 94 - 103
  • [4] Compliance Analysis Based on a Goal-oriented Requirement Language Evaluation Methodology
    Ghanavati, Sepideh
    Amyot, Daniel
    Peyton, Liam
    PROCEEDINGS OF THE 2009 17TH IEEE INTERNATIONAL REQUIREMENTS ENGINEERING CONFERENCE, 2009, : 133 - 142
  • [5] ISTH clinical practice guideline for treatment of congenital hemophilia A and B based on the Grading of Recommendations Assessment, Development, and Evaluation methodology: considerations for practice management and implementation
    Ainle, Fionnuala Ni
    DiMichele, Donna
    Falck-Ytter, Yngve
    Smit, Cees
    De Paula, Erich V.
    Seth, Tulika
    Chuansumrit, Ampaiwan
    Middeldorp, Saskia
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2024, 22 (09) : 2404 - 2409
  • [6] Recommendations for European laboratories based on the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
    Cavalier, Etienne
    Zima, Tomas
    Datta, Pradip
    Makris, Konstantinos
    Schaeffner, Elke
    Langlois, Michel
    Plebani, Mario
    Delanaye, Pierre
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2025, 63 (03) : 525 - 534
  • [7] Summary of evidence-based nutritional recommendations of the Clinical Practice Guideline for the management of patients with Parkinson's disease
    Baladia, Eduard
    Frutos Perez-Surio, Alberto
    Martinez-Rodriguez, Rodrigo
    NUTRICION HOSPITALARIA, 2016, 33 (03) : 749 - 760
  • [8] International Society on Thrombosis and Haemostasis clinical practice guideline for treatment of congenital hemophilia A and B based on the Grading of Recommendations Assessment, Development, and Evaluation methodology
    Rezende, Suely M.
    Neumann, Ignacio
    Angchaisuksiri, Pantep
    Awodu, Omolade
    Boban, Ana
    Cuker, Adam
    Curtin, Julie A.
    Fijnvandraat, Karin
    Gouw, Samantha C.
    Gualtierotti, Roberta
    Makris, Michael
    Nahuelhual, Paula
    O'Connell, Niamh
    Saxena, Renu
    Shima, Midori
    Wu, Runhui
    Rosendaal, Frits R.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2024, 22 (09) : 2629 - 2652
  • [9] Structural evaluation in the management of patients with rheumatoid arthritis:: development of recommendations for clinical practice based on published evidence and expert opinion
    Gossec, L
    Fautrel, B
    Pham, T
    Combe, B
    Flipo, RM
    Goupille, P
    Le Loet, X
    Mariette, X
    Puéchal, X
    Wendling, D
    Schaeverbeke, T
    Sibilia, J
    Sany, J
    Dougados, M
    JOINT BONE SPINE, 2005, 72 (03) : 229 - 234
  • [10] Evaluation of genetic risk, its clinical manifestation and disease management based on 18 susceptibility gene markers among West-Slavonic patients with sarcoidosis
    Kishore, Amit
    Sikorova, Katerina
    Kocourkova, Lenka
    Petrkova, Jana
    Doubkova, Martina
    Jakubec, Petr
    Rebala, Krzysztof
    Dubaniewicz, Anna
    Petrek, Martin
    GENE, 2023, 878